(Q37882620)

24 August 2017

1 reference

title

Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency (English)

1 reference

24 August 2017

0 references

1 reference

Shihab Hameed

1

1 reference

24 August 2017

Adam Jaffé

series ordinal

2

1 reference

24 August 2017

Charles F Verge

series ordinal

3

1 reference

24 August 2017

language of work or name

1 reference

27 May 2011

1 reference

24 August 2017

published in

Pediatric Pulmonology

1 reference

24 August 2017

volume

46

1 reference

24 August 2017

issue

8

1 reference

24 August 2017

page(s)

747-760

1 reference

Cystic fibrosis mortality trends in France.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

A teenage girl with cystic fibrosis-related diabetes, diabetic ketoacidosis, and cerebral edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Glucose tolerance in patients with cystic fibrosis: five year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Management of cystic fibrosis-related diabetes in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Expression and localization of cystic fibrosis transmembrane conductance regulator in the rat endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Is cystic fibrosis-related diabetes an apoptotic consequence of ER stress in pancreatic cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Diabetes mellitus in cystic fibrosis: genetic and immunological markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Blood glucose and serum insulin levels in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Pancreatic alpha and beta cell functions in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Mechanisms of glucose intolerance in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Elevated gluconeogenesis and lack of suppression by insulin contribute to cystic fibrosis-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Insulin sensitivity in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Carbohydrate Tolerance in Cystic Fibrosis Is Closely Linked to Pancreatic Exocrine Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Cystic fibrosis related diabetes in an extremely young patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Hyperglycaemia and insulinopenia in a neonate with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Glucose intolerance in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Abnormal glucose metabolism in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Growth in children with cystic fibrosis-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Glucose tolerance in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Conventional measures underestimate glycaemia in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Management of cystic fibrosis related diabetes: a survey of UK cystic fibrosis centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Standards of care for patients with cystic fibrosis: a European consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Continuous glucose monitoring in adolescents with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Pulmonary function in diabetes: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Wasting as an independent predictor of mortality in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Use of the insulin pump in treat cystic fibrosis related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Predictors of mortality in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Effect of hyperglycaemia on glucose concentration of human nasal secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Microvascular complications in cystic fibrosis-related diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Cystic fibrosis-related diabetes in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Cystic fibrosis-related diabetes in children--gaps in the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

The effect of thiazolidinediones on BMD and osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

Clinical improvement in cystic fibrosis with early insulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21495

21 January 2018

Identifiers

DOI

10.1002/PPUL.21495

1 reference

24 August 2017

1 reference